Dr. Lorne Marshall Newton Babb, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 84 Water Tower Rd, Suite 1, Enosburg Falls, VT 05450 Phone: 802-933-6664 Fax: 802-933-8333 |
News Archive
The administration announces that almost 2.8 million people have saved an average $677, because the law is closing the prescription drug doughnut hole.
OSI Pharmaceuticals, Inc. and Genentech, Inc., a wholly owned member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for Tarceva® (erlotinib) as a first-line maintenance therapy in advanced non-small cell lung cancer (NSCLC) by an additional 90 days.
Glycotope GmbH, a leading glycobiology company, has won the innovation award 2010 jointly presented by the German states of Berlin and Brandenburg in recognition of the company's GlycoExpress™ technology platform. GlycoExpress™ combines a very efficient improvement of the activities and side effects of a broad range of protein biopharmaceuticals with the suitability for a much broader patient population and a very high productivity.
Tivantinib is an effective second-line therapy for hepatocellular carcinoma patients whose tumors exhibit high MET receptor tyrosine kinase expression, indicate phase II study results.
› Verified 8 days ago